{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,31]],"date-time":"2025-10-31T07:58:05Z","timestamp":1761897485420,"version":"build-2065373602"},"reference-count":55,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2021,10,1]],"date-time":"2021-10-01T00:00:00Z","timestamp":1633046400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,10,1]],"date-time":"2021-10-01T00:00:00Z","timestamp":1633046400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2021,10,1]],"date-time":"2021-10-01T00:00:00Z","timestamp":1633046400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2021,10,1]],"date-time":"2021-10-01T00:00:00Z","timestamp":1633046400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2021,10,1]],"date-time":"2021-10-01T00:00:00Z","timestamp":1633046400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2021,10,1]],"date-time":"2021-10-01T00:00:00Z","timestamp":1633046400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2021,10,1]],"date-time":"2021-10-01T00:00:00Z","timestamp":1633046400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Critical Care"],"published-print":{"date-parts":[[2021,10]]},"DOI":"10.1016\/j.jcrc.2021.05.017","type":"journal-article","created":{"date-parts":[[2021,5,31]],"date-time":"2021-05-31T11:54:05Z","timestamp":1622462045000},"page":"65-71","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":8,"special_numbering":"C","title":["Vasopressor and inotrope treatment for septic shock: An umbrella review of reviews"],"prefix":"10.1016","volume":"65","author":[{"given":"Sharon","family":"Einav","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yigal","family":"Helviz","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mariachiara","family":"Ippolito","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Andrea","family":"Cortegiani","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"author":"website OCfE-BM","key":"10.1016\/j.jcrc.2021.05.017_bb0005"},{"issue":"10","key":"10.1016\/j.jcrc.2021.05.017_bb0010","doi-asserted-by":"crossref","first-page":"1006","DOI":"10.1016\/j.jclinepi.2009.06.005","article-title":"Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement","volume":"62","author":"Moher","year":"2009","journal-title":"J. Clin. Epidemiol."},{"issue":"5","key":"10.1016\/j.jcrc.2021.05.017_bb0015","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pmed.1002028","article-title":"Epidemiology and reporting characteristics of systematic reviews of biomedical research: a cross-sectional study","volume":"13","author":"Page","year":"2016","journal-title":"PLoS Med."},{"issue":"3","key":"10.1016\/j.jcrc.2021.05.017_bb0020","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pmed.0040078","article-title":"Epidemiology and reporting characteristics of systematic reviews","volume":"4","author":"Moher","year":"2007","journal-title":"PLoS Med."},{"issue":"8","key":"10.1016\/j.jcrc.2021.05.017_bb0025","doi-asserted-by":"crossref","first-page":"2758","DOI":"10.1097\/00003246-200008000-00012","article-title":"Effect of norepinephrine on the outcome of septic shock","volume":"28","author":"Martin","year":"2000","journal-title":"Crit. Care Med."},{"issue":"6","key":"10.1016\/j.jcrc.2021.05.017_bb0030","doi-asserted-by":"crossref","first-page":"1826","DOI":"10.1378\/chest.103.6.1826","article-title":"Norepinephrine or dopamine for the treatment of hyperdynamic septic shock?","volume":"103","author":"Martin","year":"1993","journal-title":"Chest"},{"issue":"3","key":"10.1016\/j.jcrc.2021.05.017_bb0035","doi-asserted-by":"crossref","first-page":"858","DOI":"10.1097\/01.CCM.0000117317.18092.E4","article-title":"Surviving sepsis campaign guidelines for management of severe sepsis and septic shock","volume":"32","author":"Dellinger","year":"2004","journal-title":"Crit. Care Med."},{"issue":"2","key":"10.1016\/j.jcrc.2021.05.017_bb0040","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1007\/BF01683060","article-title":"Haemodynamic effects of dopamine in septic shock","volume":"3","author":"Regnier","year":"1977","journal-title":"Intensive Care Med."},{"issue":"6","key":"10.1016\/j.jcrc.2021.05.017_bb0045","doi-asserted-by":"crossref","first-page":"1659","DOI":"10.1097\/01.CCM.0000063045.77339.B6","article-title":"Effects of dopamine, norepinephrine, and epinephrine on the splanchnic circulation in septic shock: which is best?","volume":"31","author":"De Backer","year":"2003","journal-title":"Crit. Care Med."},{"author":"website JBI","key":"10.1016\/j.jcrc.2021.05.017_bb0050"},{"issue":"6","key":"10.1016\/j.jcrc.2021.05.017_bb0055","doi-asserted-by":"crossref","first-page":"1644","DOI":"10.1378\/chest.101.6.1644","article-title":"Definitions for sepsis and organ failure and guidelines for the use of innovative therapies in sepsis. The ACCP\/SCCM Consensus Conference Committee. American College of Chest Physicians\/Society of Critical Care Medicine","volume":"101","author":"Bone","year":"1992","journal-title":"Chest"},{"issue":"1","key":"10.1016\/j.jcrc.2021.05.017_bb0060","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1093\/ije\/31.1.115","article-title":"Direction and impact of language bias in meta-analyses of controlled trials: empirical study","volume":"31","author":"Juni","year":"2002","journal-title":"Int. J. Epidemiol."},{"issue":"41","key":"10.1016\/j.jcrc.2021.05.017_bb0065","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3310\/hta7410","article-title":"The inclusion of reports of randomised trials published in languages other than English in systematic reviews","volume":"7","author":"Moher","year":"2003","journal-title":"Health Technol. Assess."},{"key":"10.1016\/j.jcrc.2021.05.017_bb0070","doi-asserted-by":"crossref","first-page":"j4008","DOI":"10.1136\/bmj.j4008","article-title":"AMSTAR 2: a critical appraisal tool for systematic reviews that include randomised or non-randomised studies of healthcare interventions, or both","volume":"358","author":"Shea","year":"2017","journal-title":"BMJ"},{"issue":"2","key":"10.1016\/j.jcrc.2021.05.017_bb0075","first-page":"134","article-title":"Effect of terlipressin on prognosis of adult septic shock patients: a meta-analysis","volume":"32","author":"Li","year":"2020","journal-title":"Zhonghua Wei Zhong Bing Ji Jiu Yi Xue"},{"key":"10.1016\/j.jcrc.2021.05.017_bb0080","doi-asserted-by":"crossref","DOI":"10.1002\/14651858.CD003709.pub2","article-title":"Vasopressors for shock","volume":"3","author":"Mullner","year":"2004","journal-title":"Cochrane Database Syst. Rev."},{"key":"10.1016\/j.jcrc.2021.05.017_bb0085","doi-asserted-by":"crossref","DOI":"10.1002\/14651858.CD003709.pub3","article-title":"Vasopressors for hypotensive shock","volume":"5","author":"Havel","year":"2011","journal-title":"Cochrane Database Syst. Rev."},{"issue":"9","key":"10.1016\/j.jcrc.2021.05.017_bb0090","doi-asserted-by":"crossref","first-page":"1322","DOI":"10.1007\/s00134-016-4449-6","article-title":"Milrinone for cardiac dysfunction in critically ill adult patients: a systematic review of randomised clinical trials with meta-analysis and trial sequential analysis","volume":"42","author":"Koster","year":"2016","journal-title":"Intensive Care Med."},{"issue":"1","key":"10.1016\/j.jcrc.2021.05.017_bb0095","doi-asserted-by":"crossref","first-page":"488","DOI":"10.1186\/s13054-020-03204-x","article-title":"Timing of norepinephrine initiation in patients with septic shock: a systematic review and meta-analysis","volume":"24","author":"Li","year":"2020","journal-title":"Crit. Care"},{"key":"10.1016\/j.jcrc.2021.05.017_bb0100","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1186\/s40560-019-0369-1","article-title":"Terlipressin for septic shock patients: a meta-analysis of randomized controlled study","volume":"7","author":"Zhu","year":"2019","journal-title":"J. Intensive Care"},{"key":"10.1016\/j.jcrc.2021.05.017_bb0105","doi-asserted-by":"crossref","first-page":"1047","DOI":"10.2147\/TCRM.S80060","article-title":"Vasopressors in septic shock: a systematic review and network meta-analysis","volume":"11","author":"Zhou","year":"2015","journal-title":"Ther. Clin. Risk Manag."},{"issue":"1","key":"10.1016\/j.jcrc.2021.05.017_bb0110","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1186\/s40560-020-00500-0","article-title":"Non-catecholamine vasopressors in the treatment of adult patients with septic shock-evidence from meta-analysis and trial sequential analysis of randomized clinical trials","volume":"8","author":"Zhong","year":"2020","journal-title":"J. Intensive Care"},{"issue":"5","key":"10.1016\/j.jcrc.2021.05.017_bb0115","doi-asserted-by":"crossref","first-page":"908","DOI":"10.1016\/j.jcrc.2015.05.017","article-title":"Levosimendan reduces mortality in patients with severe sepsis and septic shock: a meta-analysis of randomized trials","volume":"30","author":"Zangrillo","year":"2015","journal-title":"J. Crit. Care"},{"key":"10.1016\/j.jcrc.2021.05.017_bb0120","doi-asserted-by":"crossref","first-page":"563","DOI":"10.3389\/fphar.2020.00563","article-title":"Clinical efficiency of vasopressin or its analogs in comparison with catecholamines alone on patients with septic shock: a systematic review and meta-analysis","volume":"11","author":"Yao","year":"2020","journal-title":"Front. Pharmacol."},{"issue":"59","key":"10.1016\/j.jcrc.2021.05.017_bb0125","doi-asserted-by":"crossref","first-page":"100524","DOI":"10.18632\/oncotarget.20123","article-title":"Effects of levosimendan on mortality in patients with septic shock: systematic review with meta-analysis and trial sequential analysis","volume":"8","author":"Wang","year":"2017","journal-title":"Oncotarget"},{"issue":"3","key":"10.1016\/j.jcrc.2021.05.017_bb0130","doi-asserted-by":"crossref","first-page":"172","DOI":"10.1177\/0885066610396312","article-title":"Norepinephrine or dopamine for septic shock: systematic review of randomized clinical trials","volume":"27","author":"Vasu","year":"2012","journal-title":"J. Intensive Care Med."},{"issue":"4","key":"10.1016\/j.jcrc.2021.05.017_bb0135","doi-asserted-by":"crossref","first-page":"R154","DOI":"10.1186\/cc11469","article-title":"Vasopressin and terlipressin in adult vasodilatory shock: a systematic review and meta-analysis of nine randomized controlled trials","volume":"16","author":"Serpa Neto","year":"2012","journal-title":"Crit. Care"},{"issue":"4","key":"10.1016\/j.jcrc.2021.05.017_bb0140","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1177\/0885066618818460","article-title":"Novel vasopressors in the treatment of vasodilatory shock: a systematic review of angiotensin II, selepressin, and terlipressin","volume":"35","author":"Rodriguez","year":"2020","journal-title":"J. Intensive Care Med."},{"issue":"1","key":"10.1016\/j.jcrc.2021.05.017_bb0145","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1007\/s00134-011-2407-x","article-title":"Vasopressin for treatment of vasodilatory shock: an ESICM systematic review and meta-analysis","volume":"38","author":"Polito","year":"2012","journal-title":"Intensive Care Med."},{"issue":"5","key":"10.1016\/j.jcrc.2021.05.017_bb0150","doi-asserted-by":"crossref","first-page":"706","DOI":"10.1016\/j.jcrc.2014.04.011","article-title":"Mortality benefit of vasopressor and inotropic agents in septic shock: a Bayesian network meta-analysis of randomized controlled trials","volume":"29","author":"Oba","year":"2014","journal-title":"J. Crit. Care"},{"issue":"1","key":"10.1016\/j.jcrc.2021.05.017_bb0155","doi-asserted-by":"crossref","first-page":"e44","DOI":"10.1097\/CCM.0000000000003471","article-title":"Renal outcomes of vasopressin and its analogs in distributive shock: a systematic review and meta-analysis of randomized trials","volume":"47","author":"Nedel","year":"2019","journal-title":"Crit. Care Med."},{"issue":"2","key":"10.1016\/j.jcrc.2021.05.017_bb0160","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1177\/1751143715620203","article-title":"Comparative safety and efficacy of vasopressors for mortality in septic shock: a network meta-analysis","volume":"17","author":"Nagendran","year":"2016","journal-title":"J Intensive Care Soc"},{"issue":"18","key":"10.1016\/j.jcrc.2021.05.017_bb0165","doi-asserted-by":"crossref","first-page":"1889","DOI":"10.1001\/jama.2018.4528","article-title":"Association of vasopressin plus catecholamine vasopressors vs catecholamines alone with atrial fibrillation in patients with distributive shock: a systematic review and meta-analysis","volume":"319","author":"McIntyre","year":"2018","journal-title":"JAMA"},{"issue":"1","key":"10.1016\/j.jcrc.2021.05.017_bb0170","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1186\/s13054-019-2362-4","article-title":"The effects and safety of vasopressin receptor agonists in patients with septic shock: a meta-analysis and trial sequential analysis","volume":"23","author":"Jiang","year":"2019","journal-title":"Crit. Care"},{"issue":"5","key":"10.1016\/j.jcrc.2021.05.017_bb0175","doi-asserted-by":"crossref","first-page":"400","DOI":"10.1631\/jzus.B1200290","article-title":"Levosimendan versus dobutamine in critically ill patients: a meta-analysis of randomized controlled trials","volume":"14","author":"Huang","year":"2013","journal-title":"J Zhejiang Univ Sci B"},{"key":"10.1016\/j.jcrc.2021.05.017_bb0180","doi-asserted-by":"crossref","first-page":"1492","DOI":"10.3389\/fphar.2019.01492","article-title":"Terlipressin versus norepinephrine for septic shock: a systematic review and meta-analysis","volume":"10","author":"Huang","year":"2019","journal-title":"Front. Pharmacol."},{"issue":"4","key":"10.1016\/j.jcrc.2021.05.017_bb0185","doi-asserted-by":"crossref","first-page":"424","DOI":"10.1111\/aas.13294","article-title":"Dopamine in critically ill patients with cardiac dysfunction: a systematic review with meta-analysis and trial sequential analysis","volume":"63","author":"Hiemstra","year":"2019","journal-title":"Acta Anaesthesiol. Scand."},{"key":"10.1016\/j.jcrc.2021.05.017_bb0190","article-title":"Vasopressors for hypotensive shock","volume":"2","author":"Gamper","year":"2016","journal-title":"Cochrane Database Syst. Rev."},{"issue":"3","key":"10.1016\/j.jcrc.2021.05.017_bb0195","doi-asserted-by":"crossref","first-page":"725","DOI":"10.1097\/CCM.0b013e31823778ee","article-title":"Dopamine versus norepinephrine in the treatment of septic shock: a meta-analysis*","volume":"40","author":"De Backer","year":"2012","journal-title":"Crit. Care Med."},{"issue":"1","key":"10.1016\/j.jcrc.2021.05.017_bb0200","doi-asserted-by":"crossref","first-page":"168","DOI":"10.1186\/s13054-019-2427-4","article-title":"Comparative efficacy of vasoactive medications in patients with septic shock: a network meta-analysis of randomized controlled trials","volume":"23","author":"Cheng","year":"2019","journal-title":"Crit. Care"},{"issue":"3","key":"10.1016\/j.jcrc.2021.05.017_bb0205","doi-asserted-by":"crossref","DOI":"10.1136\/bmjopen-2017-019338","article-title":"Effect of levosimendan on mortality in severe sepsis and septic shock: a meta-analysis of randomised trials","volume":"8","author":"Chang","year":"2018","journal-title":"BMJ Open"},{"key":"10.1016\/j.jcrc.2021.05.017_bb0210","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1016\/j.jclinane.2017.03.011","article-title":"Levosimendan does not provide mortality benefit over dobutamine in adult patients with septic shock: a meta-analysis of randomized controlled trials","volume":"39","author":"Bhattacharjee","year":"2017","journal-title":"J. Clin. Anesth."},{"issue":"3","key":"10.1016\/j.jcrc.2021.05.017_bb0215","doi-asserted-by":"crossref","first-page":"398","DOI":"10.1097\/CCM.0000000000004127","article-title":"Effect of continuous epinephrine infusion on survival in critically ill patients: a meta-analysis of randomized trials","volume":"48","author":"Belletti","year":"2020","journal-title":"Crit. Care Med."},{"issue":"11","key":"10.1016\/j.jcrc.2021.05.017_bb0220","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0142605","article-title":"Non-adrenergic vasopressors in patients with or at risk for vasodilatory shock. A systematic review and meta-analysis of randomized trials","volume":"10","author":"Belletti","year":"2015","journal-title":"PLoS One"},{"issue":"5","key":"10.1016\/j.jcrc.2021.05.017_bb0225","doi-asserted-by":"crossref","first-page":"656","DOI":"10.1093\/bja\/aev284","article-title":"The effect of inotropes and vasopressors on mortality: a meta-analysis of randomized clinical trials","volume":"115","author":"Belletti","year":"2015","journal-title":"Br. J. Anaesth."},{"key":"10.1016\/j.jcrc.2021.05.017_bb0230","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1016\/j.jcrc.2016.08.010","article-title":"The effect of vasoactive drugs on mortality in patients with severe sepsis and septic shock. A network meta-analysis of randomized trials","volume":"37","author":"Belletti","year":"2017","journal-title":"J. Crit. Care"},{"issue":"8","key":"10.1016\/j.jcrc.2021.05.017_bb0235","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0129305","article-title":"Vasopressors for the treatment of septic shock: systematic review and meta-analysis","volume":"10","author":"Avni","year":"2015","journal-title":"PLoS One"},{"issue":"9","key":"10.1016\/j.jcrc.2021.05.017_bb0240","doi-asserted-by":"crossref","first-page":"779","DOI":"10.1056\/NEJMoa0907118","article-title":"Comparison of dopamine and norepinephrine in the treatment of shock","volume":"362","author":"De Backer","year":"2010","journal-title":"N. Engl. J. Med."},{"issue":"1","key":"10.1016\/j.jcrc.2021.05.017_bb0245","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1186\/s13613-021-00806-8","article-title":"Current use of inotropes in circulatory shock","volume":"11","author":"Scheeren","year":"2021","journal-title":"Ann. Intensive Care"},{"issue":"8","key":"10.1016\/j.jcrc.2021.05.017_bb0250","doi-asserted-by":"crossref","first-page":"801","DOI":"10.1001\/jama.2016.0287","article-title":"The third international consensus definitions for Sepsis and septic shock (Sepsis-3)","volume":"315","author":"Singer","year":"2016","journal-title":"JAMA"},{"issue":"8179","key":"10.1016\/j.jcrc.2021.05.017_bb0255","first-page":"1172","article-title":"Aspirin after myocardial infarction","volume":"1","year":"1980","journal-title":"Lancet"},{"issue":"10","key":"10.1016\/j.jcrc.2021.05.017_bb0260","doi-asserted-by":"crossref","first-page":"3","DOI":"10.3102\/0013189X005010003","article-title":"Primary, secondary, and meta-analysis of research","volume":"5","author":"Glass","year":"1976","journal-title":"Educ. Res."},{"issue":"3","key":"10.1016\/j.jcrc.2021.05.017_bb0265","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0059202","article-title":"The impact of study size on meta-analyses: examination of underpowered studies in Cochrane reviews","volume":"8","author":"Turner","year":"2013","journal-title":"PLoS One"},{"key":"10.1016\/j.jcrc.2021.05.017_bb0270","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1186\/1471-2288-10-23","article-title":"Can we rely on the best trial? A comparison of individual trials and systematic reviews","volume":"10","author":"Glasziou","year":"2010","journal-title":"BMC Med. Res. Methodol."},{"issue":"9","key":"10.1016\/j.jcrc.2021.05.017_bb0275","doi-asserted-by":"crossref","first-page":"877","DOI":"10.1056\/NEJMoa067373","article-title":"Vasopressin versus norepinephrine infusion in patients with septic shock","volume":"358","author":"Russell","year":"2008","journal-title":"N. Engl. J. Med."}],"container-title":["Journal of Critical Care"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0883944121001040?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0883944121001040?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,10]],"date-time":"2025-10-10T19:47:35Z","timestamp":1760125655000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0883944121001040"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,10]]},"references-count":55,"alternative-id":["S0883944121001040"],"URL":"https:\/\/doi.org\/10.1016\/j.jcrc.2021.05.017","relation":{},"ISSN":["0883-9441"],"issn-type":[{"type":"print","value":"0883-9441"}],"subject":[],"published":{"date-parts":[[2021,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Vasopressor and inotrope treatment for septic shock: An umbrella review of reviews","name":"articletitle","label":"Article Title"},{"value":"Journal of Critical Care","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jcrc.2021.05.017","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}